GlassScriptPhysician profile
Ramanathan Madras Seshadri
NPI 1891969937
$3,618.37
in general payments reported to CMS, 2019-2025
13 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $157 · 2023: $534 · 2024: $2,456 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,372 · Education: $1,000 · Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,371.60 |
| Education | $1,000.00 |
| Food and Beverage | $940.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,207.42 | 2021-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $686.40 | 2021-2025 | Endo Gia Ultra, Signia, Pteye Parathyroid Detection System |
| Boston Scientific Corporation | $164.71 | 2022-2023 | Spyglass |
| Medical Device Business Services, INC. | $139.70 | 2024 | Enseal |
| Vertex Pharmaceuticals Incorporated | $120.30 | 2025 | |
| Olympus America INC. | $69.39 | 2024 | Olympus, Gastrointestinal Videoscope |
| Intera Oncology, INC | $62.20 | 2025 | Intera |
| Davol INC. | $45.85 | 2024 | |
| Dilon Technologies, INC. | $34.61 | 2024 | Hemoblast Bellows |
| Solventum Corporation | $28.12 | 2025 | V.A.C.Ulta, Prevena |
| Smith+Nephew, INC. | $22.92 | 2025 | Grafix, Stravix |
| Merck Sharp & Dohme LLC | $18.97 | 2022 | |
| Kerecis Limited | $17.78 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramanathan Madras Seshadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.